
Lifecore Biomedical Inc
NASDAQ:LFCR

Lifecore Biomedical Inc
Total Other Income
Lifecore Biomedical Inc
Total Other Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Total Other Income
$18.3m
|
CAGR 3-Years
293%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
![]() |
Hershey Co
NYSE:HSY
|
Total Other Income
-$258.6m
|
CAGR 3-Years
-265%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
-58%
|
|
![]() |
General Mills Inc
NYSE:GIS
|
Total Other Income
$66.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Kellogg Co
NYSE:K
|
Total Other Income
-$13m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Kraft Heinz Co
NASDAQ:KHC
|
Total Other Income
$121m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
![]() |
Mondelez International Inc
NASDAQ:MDLZ
|
Total Other Income
$424m
|
CAGR 3-Years
25%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

See Also
What is Lifecore Biomedical Inc's Total Other Income?
Total Other Income
18.3m
USD
Based on the financial report for Nov 24, 2024, Lifecore Biomedical Inc's Total Other Income amounts to 18.3m USD.
What is Lifecore Biomedical Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
17%
Over the last year, the Total Other Income growth was -6%. The average annual Total Other Income growth rates for Lifecore Biomedical Inc have been 293% over the past three years , and 17% over the past ten years .